HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care,…
An institutional-grade, numbers-driven thesis on HCA — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of August 8, 2026, TradersQuant's model rates HCA Healthcare, Inc. (HCA) 65/100 with a 12-month base-case forecast of $455.19 — +10.1% versus the current price of $413.36. HCA Healthcare, Inc. trades at $413.36 in the Healthcare sector, with a market capitalisation of $89.49B. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month analyst consensus price target for HCA is $455.19, implying +10.1% versus the current price. The model's 12-month scenario range runs from $401.25 (bear) to $570.72 (bull), with a base case of $461.76.
On the fundamentals, HCA Healthcare shows a P/E of 13.8, trailing revenue of $75.60B, revenue growth of +7.1% YoY, a dividend yield of 0.73%. This page also tracks HCA's short interest, institutional (smart-money) positioning and the options market — the same cross-signal view institutions watch.
HCA currently carries a TradersQuant composite score of 65/100, which we read as a neutral-to-watch signal. The Wall-Street analyst consensus is "Buy". Our 12-month price target of $455.19 implies +10.1% from $413.36. This is research, not financial advice — always combine it with your own judgement.
The analyst consensus price target for HCA is $455.19, about +10.1% versus the latest price of $413.36. Consensus is based on 46 analysts.
TradersQuant's 12-month model forecast for HCA is a base case of $461.76, ranging from $401.25 (bear) to $570.72 (bull), an expected return of +11.7%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for HCA over the next 12 months is $461.76 in the base case (bear $401.25, bull $570.72), versus today's price of $413.36. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for HCA — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates HCA's fair value at $455.19, implying +10.1% of expected upside versus the current price.
Yes — HCA Healthcare pays a dividend yielding 0.73% (about $3.00 per share annually).
Data and model outputs are for research only and are not financial advice. Figures update continuously.
